Provided by Tiger Trade Technology Pte. Ltd.

XTALPI

9.600
+0.3303.56%
Volume:59.36M
Turnover:562.88M
Market Cap:41.31B
PE:282.79
High:9.700
Open:9.240
Low:9.120
Close:9.270
52wk High:15.120
52wk Low:3.850
Shares:4.30B
HK Float Shares:4.30B
Volume Ratio:1.07
T/O Rate:1.38%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.034
ROE:2.01%
ROA:-3.96%
PB:3.89
PE(LYR):282.79
PS:45.48

Loading ...

Southbound Capital Flow Data (T+2) for Hong Kong Stocks | Nov 24

Stock News
·
Nov 24, 2025

XTALPI (02228) Issues 225,000 Shares Under Share Scheme

Stock News
·
Nov 20, 2025

XtalPi (02228) Publishes Next Day Disclosure Return and Announces New Share Issuance

Bulletin Express
·
Nov 20, 2025

XtalPi Holdings (SEHK:2228) Is Up 6.6% After Eli Lilly Endorses Ailux AI Platform Partnership Has The Bull Case Changed?

Simply Wall St.
·
Nov 12, 2025

Prenetics Global Ltd Qtrly Loss per Share From Continuing Operations $0.41

THOMSON REUTERS
·
Nov 10, 2025

XTALPI (02228): AI Innovation Platform Successfully Develops Hair Growth "Twin Star" Molecules, Secures Key International Certification

Stock News
·
Nov 10, 2025

XtalPi Unveils AI-Developed Molecules for Hair Growth

Reuters
·
Nov 10, 2025

Active Southbound Trading in Hong Kong Stocks | November 6

Stock News
·
Nov 06, 2025

XTALPI (02228) Included in MSCI China Index, Global Benchmark Recognizes Growth Potential

Stock News
·
Nov 06, 2025

HK Movers | XtalPi Stock Jumps 5% as Its Subsidiary Ailux Partners with Lilly on AI-Driven Bispecific Antibody Development

Reuters
·
Nov 06, 2025

North America's AI Expansion Faces Power Shortages; SK Hynix's HBM4 Supply to NVIDIA Priced 50% Higher Than Previous Gen

Stock News
·
Nov 06, 2025

Xtalpi - Unit in Strategic Collaboration With Lilly to Advance AI Driven Bispecific Antibody Development

THOMSON REUTERS
·
Nov 05, 2025

XtalPi Holdings (02228) Announces Monthly Return, Authorized Share Capital Remains US$1,000,000

Bulletin Express
·
Nov 05, 2025

XtalPi Subsidiary Ailux Announces Bispecific Antibody Collaboration with Lilly Worth Up to $345 Million

Reuters
·
Nov 05, 2025

Ailux- Under Deal, Lilly May Nominate Target Pairs for Bispecific Antibody and Obtain Platform License

THOMSON REUTERS
·
Nov 05, 2025

Ailux: Total Potential Value of Deal Is up to $345 Mln

THOMSON REUTERS
·
Nov 05, 2025

Xtalpi Subsidiary Ailux Announces Strategic Collaboration With Lilly to Advance Bispecific Antibody Development

THOMSON REUTERS
·
Nov 05, 2025

BRIEF-Prenetics Global Says Aryna Sabalenka Expands Her Stake In Prenetics

Reuters
·
Oct 27, 2025

Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering With Potential for $216 Million in Total Proceeds to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy

THOMSON REUTERS
·
Oct 27, 2025

Prenetics Global Ltd: Aryna Sabalenka Expands Her Stake in Prenetics

THOMSON REUTERS
·
Oct 27, 2025